Catalyst Pharmaceutical (CPRX) Tops Q4 Earnings and Revenue Estimates

Catalyst Pharmaceutical (CPRX) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.22 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 10.42%. A quarter ago, it was expected that this specialty drug company would post a loss of $0.24 per share when it actually produced a loss of $0.24, delivering no surprise.Over the last four quarters, th ...